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Abstract  
The 10-year drug strategy for England and Wales was published in February 2008. It 
dropped drugs-related deaths (DRDs) as a key performance indicator. Scotland retained a 
necessary strong focus on DRDs. Scotland’s DRDs numbered 1,006 in 2000-02 and 
1,009 in 2003-05. The previous Scottish administration’s claim that its number of current 
injectors had decreased substantially between 2000 and 2003 implied, paradoxically, that 
their DRD rate would have to have increased.  Worse was to come: Scotland’s DRDs had 
increased to 876 in 2006+2007.  
 
We analyse UK’s DRDs by sex and age-group to reveal temporal trends (2000-02 versus 
2003-05 versus 2006+2007) with different public health and epidemiological 
implications. We also address the above Scottish paradox and assess, by age-group, how 
consistent Scotland’s 876 DRDs in 2006+07 are with Scottish injectors’ DRD rate in 
2003-05 of around 1 per 100 injector-years.  
 
Public health success in the UK in reducing DRDs at younger ages should not be 
overshadowed by the late consequence (older-age DRDs) of UK’s injector epidemics: in 
the early 1980s in Scotland, and late 1980s in England and Wales. Targets for reducing 
DRDs should pay heed to UK’s injector epidemics. [188 words] 
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Introduction 
A new drug strategy for England and Wales (2008-18) was published in February 2008 
(HM Government, 2008). Drugs-related deaths (DRDs) were dropped as a key 
performance indicator, perhaps because the previous target – to reduce DRDs by 20% 
between 1999 and 2004 – had been missed (Morgan et al., 2006; Report, 2007). Only a 
9% reduction could be claimed (Morgan et al., 2006) when DRDs were defined in 
accordance with recommendations by the Advisory Council on the Misuse of Drugs 
(2000) (ACMD). 
 
Scotland’s new drugs strategy, Road to Recovery, was published in May 2008 (The 
Scottish Government, 2008a).  In the wake of Scotland’s confidential inquiry into DRDs 
in 2003 (Zador et al., 2005) and specific recommendations in 2007 by a National Forum 
on Drug-Related Deaths (2007), DRDs have remained firmly in focus with the Scottish 
Government (2008a, 2008b). A newly designed national database was launched in 
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January 2009 for collecting and analysing standardised information on all Scotland’s 
DRDs.  
 
According to ACMD’s recommended definition, Scotland’s DRDs numbered 1,006 and 
1,009 in the 3-year periods of 2000-02 and 2003-05 respectively; but 876 in the most 
recently published two years (2006+2007), which gave a total of 2,891 for the 8-year 
period of 2000-07 (Information Services Division, 2008). For England and Wales, 
according to the same definition but by the registration year of deaths, DRDs at all ages 
were 5,022 in 2000-02, lower at 4,534 in 2003-05; and 3,177 in the most recently 
published two years (2006+07), which gave a total of 12,733 for 2000-07  (Report, 2008).  
 
Most DRDs are opiate-related, and they mostly occur in injecting drug users (IDUs). We 
therefore delve deeper – firstly, to analyse by age-group because the epidemic history of 
injection drug use in the UK requires it (Bird et al., 2003) and, secondly, to address a 
Scottish paradox about injectors’ DRD rate having apparently increased in 2003-05. 
 
By analysing within age-group (Bird et al., 2003), we show, first, that the above 3-year 
totals obscure public health success, in terms of very significant reductions in UK’s 
DRDs at younger ages. However, we also reveal the late epidemiological consequence of 
UK’s national epidemics of injecting drug use in the 1980s. Morgan et al. (2008) 
recently, and rightly, called for a better international understanding of the mechanisms 
that underlie overdose mortality statistics than mere age-standardisation to a common 
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European population allows (Morgan et al., 2006). Age-standardisation masks, rather 
than reveals, trends which are importantly different by age.  
 
The differences by age that we reveal have their origin in the epidemic nature of injecting 
drug use. The number of current IDUs was estimated to have increased 6-fold in Scotland 
between 1980-89 (Hutchinson et al., 2006). The corresponding increase in England was at 
least 4-fold between 1987-96 (De Angelis et al., 2004), and so somewhat delayed. These 
time periods, while not exact and subsuming of sub-national variation, are sufficiently 
different for us to anticipate that any sharp 1980s-related increase in DRDs in older-age 
IDUs may be relatively delayed in England compared to Scotland (and possibly also less 
sharp). The Health Protection Agency (2005) refers also to an earlier (smaller) IDU 
epidemic prior to 1970 in England and Wales. 
 
The Scottish paradox arose as follows. Because DRDs are mainly opiate-related and 
occur mostly in IDUs, there is reason to estimate DRDs rates per 100 current IDUs (Bird 
et al., 2003), a relevant denominator, as recommended by ACMD (2000). Capture-
recapture estimates of Scotland’s current IDUs in 2000 (see Hay et al., 2001; King et al., 
2005; Bird et al., 2003)  and again in 2003 (Hay et al., 2005; King et al., 2008) were 
publicly reported (Scottish Government News Release, 2005) as suggesting that the 
prevalent number of IDUs had decreased from 25,000 in 2000 to nearer 19,000 by 2003. 
Since Scotland’s DRDs had been 1,006 in 2000-02 and 1,009 in 2003-05, we were 
concerned by the apparent paradoxical implication that Scotland’s DRD rate per 100 
current IDUs should have increased in 2003-05, and this despite enhanced access to 
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methadone maintenance, including in prisons (Information Services Division, 2006; The 
Scottish Government, 2008).  
 
To address this Scottish paradox, we here set Scotland’s markedly increased DRDs in 
2006+2007 against the backdrop of previously-published, credibly-estimated DRD rates, 
by sex and age-group, for Scottish injectors in 2003-05 (King et al., 2008). The rates were 
derived from a Bayesian capture-recapture approach to estimating the number of 
Scotland’s current IDUs in 2003, which had given a higher central estimate of around 
26,000 IDUs (King et al., 2008). 
 
Our Approach 
Scotland’s DRDs in 2000-02 and 2003-05 are summarised in eight pre-defined (Bird et 
al., 2003; King et al., 2005) subgroups (sex by age-group by region) as in our Scottish 
work hitherto. Thus, prior to Bird et al. (2003), the age-group (15-34 years; 35+ years) 
and regional subdivisions (Greater Glasgow; elsewhere in Scotland) were specifically 
selected on the basis of knowledge of Scotland’s IDU epidemic. They have been used by 
us since then to demonstrate that, as anticipated by Scotland’s IDU epidemic history, 
Scottish DRD trends are markedly different, notably by age-group. 
 
We summarise DRDs registered in England and Wales without taking cognizance of 
regional IDU epidemics and only according to publicly-available age-groups (under 30 
years, 30-39 years, 40+ years), see Report (2008).  We do so to check for a similar 
downward trend in DRDs for the youngest age-group.  
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Next, corresponding national data for the two years, 2006+2007, are presented; and 
compared to age-specific expectations from 2003-05. 
 
Finally, we exploit results from our published Bayesian capture-recapture analysis of 
Scotland’s data-sources on IDUs in 2003 (King et al., 2008) to estimate Scottish IDUs’ 
DRD rate in 2006+2007. We do this by assuming both no important change in the 
numbers of current IDUs since 2003 and that, irrespective of sex, Scottish IDUs’ DRDs 
per subgroup of interest can be approximated by counting them as 80% of the subgroup’s 
DRDs under 45 years of age plus a substantially lower proportion, 20%, of DRDs at 45+ 
years of age.  
 
For each of the eight subgroups of interest, we compare Scottish IDUs’ thus-estimated  
DRD rate in 2006+2007 with the 95% credible interval for their DRD rate in 2003-05: 
see King et al. (2008) for more detail, or Appendix for a precis. 
 
Analysis addressing three questions 
Does Scotland’s historical injector epidemic determine its age-related increase in DRDs? 
Table 1 shows that DRDs under 35 years of age decreased very significantly (p = 0.005) 
between eras: by 15%, from 672 in 2000-02 to 572 in 2003-05. But DRDs at 15-34 years 
rose again to 466 in 2006+2007, significantly up on the expectation of 381.3 based on 
2003-05 (p < 0.001). A similar rise, see below, was not evident for the youngest age-
group in England and Wales 
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Epidemiologically unsurprisingly is that Scotland’s DRDs at 35+ years of age have 
increased dramatically between eras: by 31%, from 334 in 2000-02 to 437 in 2003-05. 
And they rose still higher to 410 DRDs in 2006+2007, that is: by 41% versus expectation 
of 291.3 based on 2003-05, p < 0.001. 
 
During 2000-05, Greater Glasgow accounted for a higher proportion of DRDs at 35+ 
years of age than at 15-34 years (p = 0.02). Males accounted for a significantly lower 
proportion of DRDs at 35+ years of age (77%) than at 15-34 years (84%). Both 
observations held true for 2006+07. 
 
Table 1 here 
 
Are England and Wales following Scotland?By age-group and sex, Table 2 summarises 
5,022 DRDs registered in 2000-02 and 4,534 DRDs in 2003-05 for England and Wales. 
Between eras, there was a marked 27% reduction in DRDs under 30 years of age, which 
was sustained in 2006+2007 when there were 899 DRDs (consistent with 927.3 expected 
on the basis of 2003-05). The 30-39 year age-group showed no evidence of a rise in 
DRDs as a consequence of the later-timed injector epidemic in England and Wales (De 
Angelis et al., 2004).  Meanwhile,  the oldest age-group showed a very highly significant 
increase to 1,109 DRDs from 943.3 DRDs expected at 40+ years of age on the basis of 
2003-05 (chi-square on 1 degree of freedom = 29.1). Most of this increase was accounted 
for by DRDs in 40-49 year olds. 
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Table 2 here 
 
The Scottish paradox – is the rate of DRDs  increasing among Scottish injectors?  For the 
eight subgroups of interest, Table 3 reproduces the model-averaged central estimates of 
King et al. (2008) for Scotland’s current IDUs in 2003; and approximate numbers of 
IDU-related DRDs in 2006+2007 under our ‘best guess’ 80:20 assumption about injector 
status (see Methods). Also shown are 95% credible intervals for injectors’ DRD rate per 
annum in 2003-05 from King et al. (2008); and our derived injector-related DRD rates for 
2006+2007, see Appendix.  
 
Except for females aged 15-34 years, who had lower rates, estimates for 2003-05 were 
broadly consistent with a 1% annual DRD rate for injectors.  
 
Six out of eight point estimates for injectors’ DRD rate in 2006+2007 were at or above 
the upper bound of the corresponding 95% credible interval from 2003-05.  
 
Table 3 here 
 
Discussion 
Major sources of uncertainty hinder a full understanding of injectors’ DRD rates, namely: 
which DRDs actually pertain to IDUs, toxicology (whether opiate-related or not; and co-
presence of other drugs), and how influential the demographic factors of sex, older age 
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and region actually are on DRD rates (Bird et al., 2003; Morgan et al., 2008; King et al., 
2005; Bargagli et al., 2006).  
 
For England and Wales, as well as for Scotland, there was good news in 2000-05. Public 
health measures were beginning to make a difference by reducing DRDs at younger ages 
– to an even greater extent in the under 30s in England and Wales than in Scotland’s 
under 35s (χ2 = 5.18, p ~ 0.02).  
 
However, the UK’s target to reduce DRDs by 20% between 1999 and 2004 took no 
apparent cognizance (Bargagli et al., 2006; Bird et al., 2005) of the (different) 
epidemiology of injecting drug use in Scotland (Hutchinson et al., 2006) and England (De 
Angelis et al., 2004). Prevalent current IDUs had increased by around 6-fold in Scotland 
during 1980-89 and 4-fold in England during 1987-96. These time periods, although 
inexact, were sufficiently different for us to anticipate that a sharp increase in older-age 
IDU-related DRDs might be both delayed and less accentuated in England compared to 
Scotland. As yet, neither in 2003-05 nor in 2006+2007 have the 30-39 year old DRDs for 
England and Wales signalled an increase, as already seen in Scotland between 2000-02 
and 2003-05 for DRDs at 35+ years and a forteriori in 2006+2007 (see Table 1). Of 
course, competing age-related trends within the 30-39 year old age-group (for decrease; 
for increase) could potentially cancel each other out. 
 
No forward projections have been made from UK’s IDU epidemics in the 1980s to the 
likely numbers of DRDs among older IDUs in the 21st century for either Scotland or 
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England and Wales. There is therefore no reference-projection against which to compare, 
for example, Scotland’s 410 older DRDs in 2006+2007. Are they more numerous, or 
fewer, than would have been plausibly projected from Scotland’s historical IDU 
epidemic? We don’t know. Age-group specific projections for injector-related DRDs in 
England and Wales over the next five years would be a boon. 
 
Apparently higher DRD rates in 2006+2007 for Scotland’s IDUs, as in Table 3, could be 
due to our having used – as the only available denominator – Scotland’s estimated 
numbers of older IDUs in 2003 (Hay et al., 2005 and King et al., 2008). Some further 
increase in older IDUs in Scotland between 2003 and 2006 is, however, likely as a 
residual consequence of Scotland’s IDU-epidemic in the early 1980s; and would imply 
some over-estimation by us.  
 
Scottish DRDs under 35 years of age decreased by 15% between 2000-02 and 2003-05, 
but the 2006+2007 total of 466 represented a significant, and worrying, 22% 
recrudescence. Notably, DRDs at a younger age for England and Wales in 2006+2007 
(Report, 2008) did not mirror the rise in Scotland. Any genuine rise in DRDs at younger 
ages has a range of interpretations, all of them disquieting. They include: i) increase in 
prevalence of younger current IDUs, ii) more risky injecting patterns by younger IDUs, 
iii) differential purity in the available heroin to which less experienced IDUs may be most 
vulnerable, iv) changed predisposition to DRDs by young people’s more risky coincident 
use of other drugs including alcohol, or v) lower referral rate for drugs rehabilitation. 
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Public health scientists have tended to follow the trail of DRDs (Morgan et al., 2008) 
rather than anticipate their trajectory by making projections, as is done for the sequelae of 
other injection-related epidemics such as hepatitis C virus (Hutchinson et al., 2005). 
Ideally, targets on DRDs should be epidemiologically-informed by plausible forward 
projections. The absence of such projections may explain the UK governments’ 
reluctance to set revised DRD targets (HM Government, 2007; The Scottish Government, 
2008) for 2008-18. Separate recognition is now needed of older-age opiate-related DRDs 
as a late consequence of the UK’s historical IDU epidemics, the timing of which differed 
between (and also within) Scotland and England and Wales. More nuanced analyses of 
DRDs are therefore needed, which take account of their demography and toxicology 
simultaneously, rather than severally (Report, 2008). 
 
We urge that public health success in the UK at reducing younger-age DRDs, which are a 
consequence (mainly) of heroin injection, should be neither overlooked nor made hostage 
to fortune by disproportionate focus on rarely-lethal drugs such as cannabis (Advisory 
Council on the Misuse of Drugs, 2008). By contrast, the lethal harm from injecting heroin 
is stark, well-quantified, and well-attributed: let young lives be not lost by their, or our, 
ignorance (Surveys, Design and Statistics Subcommittee, 2008). [word count 2,268] 
 
Acknowledgement: We are grateful to Mr. Graham Jackson, formerly at General 
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to us key cross-tabulations of Scotland’s drugs-related deaths by age-group, sex and 
region which enable our estimation of drugs-related deaths by subgroup. 
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Postscript: Scotland has recently published details of its 574 DRDs in 2008, 303 of them 
were aged 15-34 years and 271 were 35+ years of age. The increase in DRDs in the 
younger age-groups is of particular concern. See  
http://www.gro-scotland.gov.uk/press/2009/drug-related-deaths-in-scotland-2008.html 
As yet, only provisional data for 2008 are available for England and Wales. 
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Appendix 
 
Our Bayesian capture-recapture analysis of Scotland’s data-sources on IDUs in 2003 
(King et al., 2008) incorporated the belief that around 80% of DRDs under 45 years of 
age pertain to IDUs but a substantially lower proportion, around 20%, do so of DRDs at 
45+ years of age.  
 
Sensitivity analysis was used to check inferences against alternative choices which 
ranged from 75% to 85% and from 15% to 35% (King et al., 2008).  
 
The 80:20 prior belief was loosely informed by a separate capture-recapture estimation of 
injector status for Scotland’s DRDs in 2003; the age distribution of IDUs; and the 
proportion of DRDs at 45+ years with no mention of opiates.  
 
Our ‘best guess’ 80:20 assumption was applied in deriving subgroup-specific 95% 
credible intervals for Scottish IDUs’ DRD rate in 2003-05 , as shown in Table 3, together 
with the Bayesian model-averaged posterior mean number of current injectors in 2003 for 
eight subgroups of interest.  
 
A 95% credible interval, as above, is the shortest interval which encompasses 95% of the 
posterior probability for the DRD rate in question. The reported credible intervals reflect 
uncertainty about the best-fitting capture-recapture models for estimating numbers of 
current injectors in 2003 as well as random variation in numbers of DRDs in 2003-05. 
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However, they do not take into account that the numbers of current IDUs in 2003 could 
under-estimate the prevalent numbers from 2006 onwards, especially so for older IDUs. 
For the eight subgroups of interest, we also applied our ‘best guess’ assumption in 
approximating the subgroup’s number of IDU-related DRDs in 2006+2007. 
 
Injectors’ DRD rate in 2006+2007 was then estimated using the Bayesian model-
averaged posterior mean for the ratio of “IDU-related DRDs to number of current 
injectors in 2003”. [word count 286] 
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Table 1.  Drugs-related deaths in 2000-02 and 2003-05; and in 2006+2007 {versus 
expectations based on 2003-05}: Scotland 
Era Scotland (male, female) Greater Glasgow Elsewhere in 
Scotland 
2000-05: 15 - 34 years of age - public health success? 
2000+01+02    672    (558,      114)   210   462 
2003+04+05    572    (482,        90)   161   411 
Demography: 
young DRDs in 
2000-05 
Males accounted for  
84% of DRDs 
(95% CI: 81% to 86%) 
Greater Glasgow accounted for  
30% of DRDs 
(95% CI: 27% to 33%) 
2006+2007    466    (402,       64)      130   336 
2003-05 based 
expectations for 
2006+2007 
  381.3 (321.3,    60.0) 
 107.3  274.0 
2000-05: 35+ years of age - late sequelae of Scotland’s injector epidemic in 1980s? 
2000+01+02   334    (269,       65)   116   218 
2003+04+05   437    (322,     115)   151   286 
Demography: 
older DRDs 
in 2000-05 
Males accounted for 
77% of DRDs  
(95%CI: 74% to 80%) 
Greater Glasgow accounted for 
35% of DRDs 
(95% CI: 31% to 38%) 
2006+2007   410    (325,       85)   145   265 
2003-05 based 
expectations for 
2006+2007 
 291.3  (214.7,   76.7) 
 100.7  190.7 
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Table 2.  Drugs-related deaths in 2000-02 and 2003-05; and in 2006+2007 {versus 
expectations based on 2003-05}: England and Wales 
Era England and Wales Males Females 
2000-05: Under 30 years of age - public health success? 
2000+01+02 1,903 1,599 304 
2003+04+05 1,391  1,130 261 
Demography of DRDs under 30 years 
in 2000-05 
Males accounted for 82.8% of DRDs 
(95% CI: 81.6% to 84.1%) 
2006+2007    899      742   157   
2003-05 based 
expectations for 
2006+2007 
  927.3  753.3 174.0 
2000-05: 30 - 39 years of age - late sequelae of injector epidemic in 1980s? 
2000+01+02 1,753 1,508 245 
2003+04+05 1,728 1,457 271 
Demography of DRDs aged 30 – 39 years 
in 2000-05 
Males accounted for 85.2% of DRDs 
(95% CI: 84.0% to 86.4%) 
2006+2007 1,169     979  190  
2003-05 based 
expectations for 
2006+2007 
1,152.0   971.3 180.7 
2000-05: 40+ years of age – late sequelae of injector epidemic in 1980s?  
2000+01+02 1,366  of whom 826 < 50 yrs 941 of whom 653 < 50 yrs 425 of whom 173 < 50 yrs 
2003+04+05 1,415 of whom 824 < 50 yrs  967 of whom 622 < 50 yrs  448 of whom 202 < 50 yrs  
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Demography of DRDs aged 40+ years 
in 2000-05 
Males accounted for 68.6% of DRDs 
(95%CI: 66.9% to 70.3%) 
2006+2007 1,109 of whom 687 < 50 yrs   816 of whom 566 < 50 yrs   293 of whom 121 < 50 yrs   
2003-05 based 
expectations for 
2006+2007 
  943.3 644.7 298.7 
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Table 3.  Using 80:20 best guess approximation for injector-related DRDs by age (see 
Appendix), injectors’ drugs-related deaths by age-group, sex and region of Scotland and 
95% credible intervals for injectors’ DRD rate in 2003-05 are shown, together with 
derived DRD rates for 2006+2007 (in italics). 
 
Greater Glasgow Elsewhere in Scotland Region 
 
 
Sex 
& 
Age-group 
Injector-
related 
DRDs: 
 
2006+2007 
totals in italics 
IDUs’ estimated 
annual DRD rate 
per 100 current 
IDUs (95% 
credible interval18 
for 2003-05); DRD 
rate in 2006+2007 
Injector-
related 
DRDs: 
 
2006+2007 
totals in italics 
IDUs’ estimated 
annual DRD rate 
per 100 current 
IDUs (95% 
credible interval18 
for 2003-05); DRD 
rate in 2006+2007 
Males:  aged 15-34 years 
Current injectors 
in 200318: model-
averaged estimate 
 
3 300 
 
10 060 
2003-05   108.0 1.11 (0.9, 1.4) 277.6 0.93 (0.8, 1.2) 
2006+2007 
  84.8 1.3 236.8 1.2 
Males:  aged 35+ years 
Current injectors 
in 200318: model-
averaged estimate 
 
2 320 
 
 3 450 
2003-05     78.6 1.14 (0.9, 1.5) 127.4 1.26 (1.0, 1.7) 
2006+2007 
  67.0 1.4 131.8 1.9 
Females:  aged 15-34 years 
 25 
Current injectors 
in 200318: model-
averaged estimate 
 
1 600 
 
 4 890 
2003-05     20.8 0.44 (0.3, 0.6)   51.2 0.36 (0.3, 0.5) 
2006+2007 
  19.2 0.6   32.0 0.3 
Females:  aged 35+ years 
Current injectors 
in 200318: model-
averaged estimate 
 
   700 
 
 1 040 
2003-05      20.6 1.00 (0.7, 1.4)    39.6 1.30 (1.0, 1.7) 
2006+2007 
  19.6 1.4    29.8 1.4 
 
